Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of ...

Fujitsu and The University of Osaka develop new technologies for chemical material energy calculations on early-FTQC quantum computers: Osaka, Japan Thursday, March 26, 2026, 17:0 ...

Cooler Refrigeration Equipment: Leading the Future with China One-Stop Cold Storage Solutions Service The global cold chain logistics market has entered a transformative era in 2026. As international ...

The £20,000 to £100,000 tier is the most efficient for B2B brand ambassador programs. Using industry leaders or Keynote ...

For the first time, astronomers have directly measured the speed of superheated gas billowing from a cauldron of stellar ...

The Nationwide Loomis Short Term Bond Fund (IS share class) underperformed the Bloomberg US Government/Credit 1-3 Year Index 1.06% versus 1.16% for the quarter. Read more here.

This is true of two high-profile proposals likely to be on the Massachusetts ballot in November. The first would impose a ...

Sydnexis, Inc., a biopharmaceutical company focused on developing a novel low-dose atropine formulation to treat pediatric progressive myopia (PPM), today announced new data from comprehensive ...